WellTheory is rethinking autoimmune care.
What’s happening: The AI-enabled virtual clinic raised a $14M Series A to scale its evidence-based, whole-body approach through employers and health plans.
Missing pieces. Treating root causes of rheumatoid arthritis, lupus, Hashimoto’s, and more, WellTheory taps RDs and coaches for nutrition and lifestyle adjustments to alleviate common symptoms.
Closing gaps. Affecting 50M Americans, autoimmune disease has doubled over 30 years. But, despite being complex to identify and treat, the average rheumatologist visit lasts 18 minutes, while specialty drugs keep climbing.
Scaling impact, WellTheory raised $5M last year to launch its AI-powered Care Hub, contextualizing televisits with symptom tracking and lab tests. Gaining momentum, it 10x’d members and 5x’d revenue, while saving Fortune 500 partners nearly $10K per patient.
Punchline: Aiming to reverse symptoms and elevate standard treatment, WellTheory will layer in support at scale.
